prostate cancer Prostate, cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Male patients who were diagnosed with clinical stage T1-T3 prostate cancers Patients with a life expectancy of 10 or more years and deemed fit for the surgery Patients who are 18 years old or more and provided written informed consent
Exclusion criteria
Exclusion criteria: Patients with a history of surgery for benign prostate hyperplasia Patients requiring extended pelvic lymph node dissection Patients requesting nerve-sparing surgery Patients with a bleeding predisposition, defined as a platelet count of 50,000 or less, or inability to discontinue antithrombotic therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The occurrence of conversion to open or laparoscopic surgery Details of intrasurgical complications, rectal, colon injury, vessel injury, bladder/ureter injury, and nerve injury Details of postoperative complications, such as type of condition, severity based on Clavien-Dindo classification, time of onset, treatment, outcome, and causal relationship | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of operation outcomes and the feasibility Total operative time and duration of each part of the surgery Blood loss and presence or absence of blood transfusion Time required for equipment setup and removal Details of equipment malfunctions, such as type, severity, time of occurrence, response, outcome, and causal relationship Evaluation of the convenieince using a visual analog scale VAS assessment of operability in each part of the surgery VAS assessment of the surgical field visibility and image clarity for the surgeon and assistant VAS assessment of the complexity of preparation, including equipment movement and draping VAS assessment of the smoothness of docking and undocking VAS assessment of the complexity of the tasks of assistants, such as instrument exchange | — |
Contacts
Okayama University Hospital